James Robinson PhD, MPH

Professor, Division Head
Health Policy and Management

  • Leonard D. Schaeffer Endowed Chair Health Economics and Policy
  • Director Berkeley Center for Health Technology

James Claude Robinson is the Leonard D. Schaeffer Professor of Health Economics and the Director of the Berkeley Center for Health Technology, which supports research projects for innovative technologies including biopharmaceuticals, medical devices, and diagnostics.

James Claude Robinson is a Professor of Health Economics in the School of Public Health at the University of California, Berkeley, where he has the title of the Leonard D. Schaeffer Endowed Chair in Health Economics and Policy. Robinson is also the Chair of the Berkeley Center for Health Technology, which supports research and professional education projects related to coverage, management, and payment methods for innovative technologies including biopharmaceuticals, medical devices, and diagnostics.

At Berkeley, Professor Robinson teaches health policy and economics, focusing on the biotechnology, medical device, insurance, physician, and hospital sectors. He has published three books and over 120 papers in scientific and policy journals such as the New England Journal of Medicine, JAMA, and Health Affairs.

  • Fellowship – Health Policy, University of California, San Francisco
  • PhD – Economics, University of California, Berkeley
  • MPH – Health Planning and Policy, University of California, Berkeley
  • BA – Economics and Philosophy, University of California, Santa Cruz
  • Biotechnology policy and strategy
  • Innovation and affordability for medical technology
  • Cardiac and orthopedic devices
  • Health insurance
  • Physician and hospital payment methods

Robinson JC, S Howell, SD Pearson. Value-based Pricing and Patient Access to Specialty Drugs. JAMA2018; 319(21):2169-2170. https://jamanetwork.com/journals/jama/fullarticle/2680859

Robinson JC, Whaley C, Brown TT. Association of Reference Pricing with Drug Selection and Spending. New England Journal of Medicine2017; 377:658-675. https://www.nejm.org/doi/10.1056/NEJMsa1700087?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dwww.ncbi.nlm.nih.gov

Robinson JC. Medicare Advantage Reimbursement to Physicians. JAMA Internal Medicine2017;177(9):1295-1296. Published online July 10. doi:10.1001/jamainternmed.2017.2689

Robinson JC, Whaley C, Brown TT. Reference Pricing Changes the Consumer Choice Architecture of Health Care. Health Affairs2017; 36(3):524-530.

Robinson JC. Value-based Physician Payment in Oncology: Public and Private Insurer Initiatives. MilbankQuarterly2017; 2017; 95(1):184-203.

Robinson JC, Whaley C, Brown TT. Impact of Reference Pricing on Consumer Choices, Laboratory Prices, and Total Spending for Diagnostic Tests. JAMA Internal Medicine2016;176(9):1353-1359. doi:10.1001/jamainternmed.2016.2492.Published online July 25, 2016.

Robinson JC, Brown TT, Whaley C, Bozic K. Consumer Choice between Hospital-based and Freestanding Facilities for Arthroscopy. Journal of Bone and Joint Surgery2015; 97:1473-81.

Robinson JC. Purchasing Medical Innovation: The Right Technology, for the Right Patient, at the Right Price. Oakland, CA: University of California Press, 2015.

Pubmed

  • PH 200J: Health Policy and Management Breadth Course
  • PH 222A: Health Care Technology Policy
  • PH 226A: Health Economics